Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C T Lambrew

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Annals of Internal Medicine|August 15, 1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II TrialE G Bovill, M L Terrin, D C Stump, et al.
JAMA|June 24, 2000
Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest painJ G Canto, M G Shlipak, W J Rogers, et al.
Circulation|February 1, 1991
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B StudyR Roberts, W J Rogers, H S Mueller, et al.
Annals of Emergency Medicine|April 28, 2000
National Heart Attack Alert Program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemiaR J Zalenski, H P Selker, C P Cannon, et al.
JAMA|June 24, 2000
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionC P Cannon, C M Gibson, C T Lambrew, et al.
Journal of the American College of Cardiology|August 1, 1991
ACC policy statement. Recommended guidelines for training in adult clinical cardiac electrophysiology. Electrophysiology/ Electrocardiography Subcommittee, American College of CardiologyN C Flowers, J A Abildskov, W F Armstrong, et al.
The American Journal of Cardiology|August 1, 1982
Task force IV: pharmacologic interventions. Emergency cardiac careR M Gunnar, C T Lambrew, W Abrams, et al.
Circulation|December 6, 2001
Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) studyK W Baran, M Nguyen, G R McKendall, et al.
American Heart Journal|November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registryB M Scirica, D J Moliterno, N R Every, et al.
The American Journal of Cardiology|November 24, 1999
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE InvestigatorsB M Scirica, D J Moliterno, N R Every, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Internal Medicine|August 15, 1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II TrialE G Bovill, M L Terrin, D C Stump, et al.
JAMA|June 24, 2000
Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest painJ G Canto, M G Shlipak, W J Rogers, et al.
Circulation|February 1, 1991
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B StudyR Roberts, W J Rogers, H S Mueller, et al.
Annals of Emergency Medicine|April 28, 2000
National Heart Attack Alert Program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemiaR J Zalenski, H P Selker, C P Cannon, et al.
JAMA|June 24, 2000
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionC P Cannon, C M Gibson, C T Lambrew, et al.
Journal of the American College of Cardiology|August 1, 1991
ACC policy statement. Recommended guidelines for training in adult clinical cardiac electrophysiology. Electrophysiology/ Electrocardiography Subcommittee, American College of CardiologyN C Flowers, J A Abildskov, W F Armstrong, et al.
The American Journal of Cardiology|August 1, 1982
Task force IV: pharmacologic interventions. Emergency cardiac careR M Gunnar, C T Lambrew, W Abrams, et al.
Circulation|December 6, 2001
Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) studyK W Baran, M Nguyen, G R McKendall, et al.
American Heart Journal|November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registryB M Scirica, D J Moliterno, N R Every, et al.
The American Journal of Cardiology|November 24, 1999
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE InvestigatorsB M Scirica, D J Moliterno, N R Every, et al.
Pageof 3